The largest database of trusted experimental protocols

439 protocols using sas enterprise guide 7

1

Power Analysis for Adipose Tissue Lipolysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To ensure adequacy of sample size, we performed power calculations using PS Software (Power and Sample Size Calculation version 3.1.6). Based on previous studies examining NEFA release from adipose tissue explants taken from fed versus 16-h fasted C57BL6/J mice with α = 0.01, δ = 100, and σ = 25 (44 (link)), power calculations showed that at least four mice per experimental group were required to ensure sufficient power to reject the null hypothesis with probability (power) 0.9 (β = 0.9). Statistical analyses were performed in SAS Enterprise Guide 7.1 (SAS Institute Inc., Cary, NC). To assess the effect of genotype within diet group on all dependent variables in our animal studies, we used the mixed model procedure. When statistically significant interactions were found, Tukey’s adjustment for multiple comparisons was used to assess the probability of difference between means. For crossover studies, we conducted paired t tests to assess differences between saline and glucagon injections within animals. For ex vivo lipolysis assays, we conducted paired t tests to assess differences between control and treatment incubations within each animal. Independent variables were identified as classification variables in all models. Raw data were plotted in GraphPad PRISM Version 8 for Windows (GraphPad Software, San Diego, CA). All data are presented as means ± SE.
+ Open protocol
+ Expand
2

Predictors of High-Cost Healthcare Use

Check if the same lab product or an alternative is used in the 5 most similar protocols
We conducted statistical analysis using SAS Enterprise Guide 7.1 (SAS Institute Inc., Cary, NC, USA). We presented descriptive statistics as percentages or mean (with confidence intervals), as appropriate. We included standardized differences. We used a logistic regression to model the dichotomous outcome variable (whether an individual is a high- or non-high-cost user). The predictor variables of interest were age, sex, income quintile, Charlson score, number of ED and hospital visits before the index admission, as well as presence of the most prevalent comorbidities. P-values of < 0.05 were considered statistically significant.
+ Open protocol
+ Expand
3

Comparing Demographic and Clinical Factors in PPA and NPA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The distributions of demographic and clinical variables were compared between the PPA and NPA cohorts using mean or proportion differences (PD) with 95% confidence intervals (CI). Univariable and multivariable modified Poisson regression was used to identify demographic and clinical variables associated with the outcomes of interest. Unadjusted and adjusted relative risks (RR) with 95% CIs are used as measures of effect size. All data was analyzed using SAS Enterprise Guide 7.1 (Cary, NC).
+ Open protocol
+ Expand
4

Predictors of Diabetes Management Changes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Population characteristics and perceived changes in diabetes management behaviors were explored using descriptive statistics. The data were inappropriate for cumulative logit models due to violation of the proportional odds assumption. Instead, baseline predictors of change in diabetes management were analyzed using nominal logistic regressions with independent variables measured at baseline and categorized outcome variables measured at follow up. The 7-point scales used as outcomes were reversed if needed to let low values consistently represent desirable status and collapsed into three levels 1–3 (positive change), 4 (unchanged), 5–7 (negative change). The “unchanged” category was used as reference.
All estimates were adjusted for age, gender, education, employment status, diabetes type, diabetes duration, diabetes-specific complications, and co-morbidities. The models were not adjusted for psychosocial variables, i.e., DDS-2, quality of life and worries due to similarities between the concepts and risk of over-adjustment. Thus, impact of psychosocial factors was estimated in independent models, each with a single psychosocial factor added. All analyses were carried out using SAS Enterprise Guide 7.1. The level of significance was p < 0.05.
+ Open protocol
+ Expand
5

Logistic Regression for Breast Cancer Margins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Univariate and multivariate logistic regression analyses were performed to test for associations between clinicopathologic features and positive resection margins. Variables that were significant in the univariate analysis were included in a multivariate model, excluding those variables that cannot reliably be assessed preoperatively (presence and extent of DCIS outside the invasive component). Analyses were restricted to patients undergoing BCS. Because there is no international consensus regarding indications for re-excision, we preformed these analyses according to two different methods. First, we compared those patients with a free or focally positive margin to patients with more than focally positive margins. Second, because several countries use the definition of “no ink on tumor” to define resection margin status, we compared patients with free margins to those with involved margins (either focally or more than focally).
Two sided p values < 0.05 were considered significant. All analyses were performed with SAS Enterprise Guide 7.1.
+ Open protocol
+ Expand
6

Statistical Analysis of Research Findings

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analyses were performed in SAS Enterprise Guide 7.1 (SAS Institute Inc., Cary, NC, USA) with a significance level of p < 0.05.
+ Open protocol
+ Expand
7

Serum YKL-40 Biomarker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Continuous data with a Gaussian distribution are presented as mean±SD. Continuous data with a non-Gaussian distribution are presented as median (interquartile range). Proportions are presented as number (n) and percentage (%). Serum YKL-40 was logarithmically transformed (log10) because of a non-Gaussian distribution.
An unpaired Student’s t-test was performed for within-group comparisons of continuous variables with a Gaussian distribution. A Wilcoxon signed-rank test was performed on the continuous data with a non-Gaussian distribution (YKL-40, pack-years, alcohol, and weekly exercise). Unpaired comparisons of categorical variables were performed with the χ2-test or Fisher’s exact test, if any expected value was below 5.
Differences in YKL-40 between groups were tested using a linear mixed model. Serum YKL-40 was logarithmically transformed (log10) to stabilize the variance.
Statistical analysis was performed using SAS Enterprise Guide 7.1 (SAS institute Inc., Cary, North Carolina, USA). A two-sided P-value below 0.05 was considered statistically significant.
+ Open protocol
+ Expand
8

Pneumococcal CAP Diagnostic Accuracy

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to determine the percentage of pneumococcal CAP confirmed both by radiography and the Binax Now® assay, a descriptive analysis of all the variables was performed. Study estimates were made with a 95% confidence interval (significance was considered as a p-value < 0.05). All calculations were done using the SAS Enterprise Guide 7.1 statistical package (SAS Institute Inc., Cary, NC, USA).
+ Open protocol
+ Expand
9

Characteristics of DTC Telemedicine Users

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the characteristics of DTC telemedicine users in comparison to consumers of other healthcare contacts, we applied multivariate logistic regression models. Separate models for the different types of healthcare contacts were specified. The dependent variables in the four models consisted of the binary variable of having made at least one visit during 2018 in respective healthcare category. The results are presented as odds ratios of the odds for each group in relation to the reference group. Since individuals are clustered within primary healthcare providers their characteristics are not independent. To adjust for the intra-cluster correlation, robust standard errors were computed using the empirical (“sandwich”) estimator. All analyses were conducted in SAS Enterprise Guide 7.1.
+ Open protocol
+ Expand
10

Evaluating Access Control and Data Sharing Preferences

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, the frequencies and percentages of the characteristics and demographics of all potential users were reported. For RQ1, frequencies for the importance of access control, adequacy of all or none access control based on data source, and default access to PHI were shown. Logistic regression was applied to evaluate the factors associated with the adequacy of access control, whether knowing it met their needs regarding adequacy, and granting default access. In the model-building procedure, a small subset of participants was excluded from the total sample because of the limited number of observations within each cell. The number of participants and the corresponding percentages were reported for the frequency analysis. Adjusted odds ratios (ORs) and 95% CIs were reported for logistic regression results.
For RQ2, the Friedman test was used to assess the difference in the number of items selected between the 2 scenarios in terms of sharing their information. The McNemar test was also performed to check if the frequency of each item differed between the 2 scenarios. All statistical analyses were conducted using SAS software (SAS Enterprise Guide 7.1; SAS Institute Inc).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!